"Amyloid-lowering treatments represent an important advance in the treatment of Alzheimer's disease but they are associated ...
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...
Figure 1: A new W-shaped structural model of E22G 40-residue beta-amyloid fibrils. RIKEN researchers have shown how the ...
Hosted on MSN12h
While Alzheimer's Might Seem Out of Your Hands, There Are a Few Risk Factors You Might Be Able To ControlAlthough doctors have been treating Alzheimer's for decades, they are still stymied as to its exact causes. For the most part ...
A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...
The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback